Jagsonpal Pharmaceuticals Limited (BOM: 507789)
India
· Delayed Price · Currency is INR 655.25
0.00 (0.00%)
At close: Jan 3, 2025
Jagsonpal Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 2, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 16,459 | 7,313 | 7,592 | 8,214 | 2,085 | 460 | Upgrade
|
| Market Cap Growth | -0.12% | -3.68% | -7.57% | 293.91% | 353.56% | -33.02% | Upgrade
|
| Enterprise Value | 15,779 | 6,290 | 7,175 | 7,748 | 1,574 | 57 | Upgrade
|
| Last Close Price | 619.85 | 276.50 | 283.31 | 306.47 | 75.42 | 16.33 | Upgrade
|
| PE Ratio | 67.73 | 32.55 | 28.41 | 43.57 | 12.22 | 5.84 | Upgrade
|
| PS Ratio | 4.84 | 3.50 | 3.21 | 3.78 | 1.11 | 0.29 | Upgrade
|
| PB Ratio | 5.57 | 3.90 | 4.78 | 6.19 | 1.71 | 0.41 | Upgrade
|
| P/TBV Ratio | 10.19 | 3.90 | 4.78 | 6.19 | 1.71 | 0.41 | Upgrade
|
| P/FCF Ratio | 19.16 | 20.94 | 16.38 | 140.06 | 7.51 | 4.58 | Upgrade
|
| P/OCF Ratio | 19.08 | 20.79 | 16.27 | 118.81 | 7.39 | 3.87 | Upgrade
|
| EV/Sales Ratio | 6.96 | 3.01 | 3.03 | 3.56 | 0.84 | 0.04 | Upgrade
|
| EV/EBITDA Ratio | 48.03 | 28.37 | 20.67 | 30.37 | 7.92 | 0.67 | Upgrade
|
| EV/EBIT Ratio | 55.13 | 29.03 | 21.18 | 32.30 | 8.38 | 0.77 | Upgrade
|
| EV/FCF Ratio | 27.56 | 18.01 | 15.49 | 132.10 | 5.67 | 0.57 | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.05 | 0.04 | - | 0.06 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 0.30 | 0.38 | 0.17 | - | 0.34 | 0.75 | Upgrade
|
| Debt / FCF Ratio | 0.17 | 0.26 | 0.13 | - | 0.24 | 0.64 | Upgrade
|
| Asset Turnover | 0.97 | 1.01 | 1.32 | 1.33 | 1.20 | 1.11 | Upgrade
|
| Inventory Turnover | 4.68 | 4.52 | 3.68 | 3.02 | 2.75 | 1.83 | Upgrade
|
| Quick Ratio | 2.07 | 8.31 | 4.91 | 2.32 | 1.89 | 1.80 | Upgrade
|
| Current Ratio | 2.95 | 10.42 | 5.97 | 4.04 | 2.98 | 2.79 | Upgrade
|
| Return on Equity (ROE) | 13.26% | 12.97% | 18.32% | 14.81% | 14.64% | 7.30% | Upgrade
|
| Return on Assets (ROA) | 7.65% | 6.57% | 11.79% | 9.13% | 7.51% | 3.25% | Upgrade
|
| Return on Capital (ROIC) | 9.28% | 7.50% | 14.23% | 11.47% | 9.54% | 4.10% | Upgrade
|
| Earnings Yield | 1.46% | 3.07% | 3.52% | 2.30% | 8.18% | 17.12% | Upgrade
|
| FCF Yield | 5.22% | 4.77% | 6.10% | 0.71% | 13.31% | 21.82% | Upgrade
|
| Dividend Yield | 0.76% | 1.81% | 1.76% | 1.31% | 1.33% | 3.06% | Upgrade
|
| Payout Ratio | 54.44% | 58.31% | - | 55.58% | 15.36% | 16.64% | Upgrade
|
| Buyback Yield / Dilution | -2.38% | -1.35% | - | - | - | - | Upgrade
|
| Total Shareholder Return | -1.62% | 0.46% | 1.76% | 1.31% | 1.33% | 3.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.